| Dr Kresent O'neille Gurtler, AUD | |
|
2460 E Wilcox Dr, Sierra Vista, AZ 85635-2841 | |
| (520) 459-0688 | |
| Not Available |
| Full Name | Dr Kresent O'neille Gurtler |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 18 Years |
| Location | 2460 E Wilcox Dr, Sierra Vista, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508075607 | NPI | - | NPPES |
| Provider Name | Southern Arizona Hearing And Balance, L.l.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1760635023 PECOS PAC ID: 1355400102 Enrollment ID: O20081107000381 |
News Archive
Columbia University Medical Center researchers have identified cells in the upper digestive tract that can give rise to Barrett's esophagus, a precursor to esophageal cancer. The discovery of this "cell of origin" promises to accelerate the development of more precise screening tools and therapies for Barrett's esophagus and esophageal adenocarcinoma, the fastest growing form of cancer in the U.S.
Gut diseases are difficult to diagnose in many cases, and their underlying dysfunction is hard to understand in many cases. Now, a new study published in the journal Molecular Omics promises to uncover a better insight into how these conditions occur and their mechanisms, by providing a deeper look at how genes interact in complex ways in health and fail to do so in disease.
Four-year results for an ongoing study of second-line bosutinib indicate that the tyrosine kinase inhibitor offers long-term efficacy with manageable side effects for patients with chronic phase chronic myeloid leukaemia.
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
American CareSource Holdings, Inc. today introduced its new DiaSource solution for containment of dialysis costs. The solution is from Ancillary Care Services (ACS), the leading national network of ancillary healthcare providers and a wholly owned subsidiary of American CareSource.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kresent O'neille Gurtler, AUD 2460 E Wilcox Dr, Sierra Vista, AZ 85635-2841 Ph: (520) 459-0688 | Dr Kresent O'neille Gurtler, AUD 2460 E Wilcox Dr, Sierra Vista, AZ 85635-2841 Ph: (520) 459-0688 |
News Archive
Columbia University Medical Center researchers have identified cells in the upper digestive tract that can give rise to Barrett's esophagus, a precursor to esophageal cancer. The discovery of this "cell of origin" promises to accelerate the development of more precise screening tools and therapies for Barrett's esophagus and esophageal adenocarcinoma, the fastest growing form of cancer in the U.S.
Gut diseases are difficult to diagnose in many cases, and their underlying dysfunction is hard to understand in many cases. Now, a new study published in the journal Molecular Omics promises to uncover a better insight into how these conditions occur and their mechanisms, by providing a deeper look at how genes interact in complex ways in health and fail to do so in disease.
Four-year results for an ongoing study of second-line bosutinib indicate that the tyrosine kinase inhibitor offers long-term efficacy with manageable side effects for patients with chronic phase chronic myeloid leukaemia.
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
American CareSource Holdings, Inc. today introduced its new DiaSource solution for containment of dialysis costs. The solution is from Ancillary Care Services (ACS), the leading national network of ancillary healthcare providers and a wholly owned subsidiary of American CareSource.
› Verified 3 days ago
Dr. Richard C Anesko, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 157 N. Coronado Drive Suite B, Sierra Vista Rural Health Care Center, Sierra Vista, AZ 85635 Phone: 520-629-4802 | |
Dr. Nicole Michelle Morris, AUD. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1989 S. Frontage Rd., Audiology Hearing And Balance Services, Sierra Vista, AZ 85602 Phone: 520-458-3383 | |
Sears Hearing Aid Center, Miracle-ear Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2250 El Mercado Loop, Sierra Vista, AZ 85635 Phone: 520-459-7559 Fax: 520-459-7559 | |
Audiology Hearing & Balance Services Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1989 Frontage Rd, Sierra Vista, AZ 85635 Phone: 520-226-9660 |